Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparative effectiveness of insulin glargine, glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter‐2 inhibitors in veterans with type 2 diabetes

Diabetes Obesity and Metabolism(2025)10.1111/dom.16207Source: DataRank Database

Comparative effectiveness of insulin glargine, glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter‐2 inhibitors in veterans with type 2 diabetes is a research paper published in Diabetes Obesity and Metabolism (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.34)OA: hybridTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Amara Sarwal,Ravinder Singh ORCID,Sydney E. Hartsell ORCID,Guo Wei ORCID,McKenna Nevers

Live enrichment

PubMed:39887855 PMC:PMC11885103 OpenAlex:https://openalex.org/W4406992231

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01 DK128640

National Institute on Aging

Grant: R01 AG074592

National Institute on Aging

Grant: T35 DK103596

National Heart, Lung, and Blood Institute

Grant: T32 HL007576

National Center for Advancing Translational Sciences

Grant: UM1TR004409

NCRR NIH HHS

Grant: UL1 RR025764

NCATS NIH HHS

Grant: UL1 TR000105

NCATS NIH HHS

Grant: UL1 TR001067

Veterans Health Administration Office of Rural Health

FWCI

1.34

Citation Percentile

0.8%

Citation Trend

2025

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.16207

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.16207

publisherhttps://dom-pubs.pericles-prod.literatumonline.com/doi/pdf/10.1111/dom.16207

journalhttps://doi.org/10.1111/dom.16207

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39887855

Fields of Study

Diabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and ResearchHumansDiabetes Mellitus, Type 2Insulin GlargineSodium-Glucose Transporter 2 InhibitorsMaleFemaleHypoglycemic AgentsMiddle AgedGlucagon-Like Peptide-1 Receptor AgonistsVeteransAgedGlycated HemoglobinCardiovascular DiseasesMetforminTreatment Outcome

MeSH Terms

Glucagon-Like Peptide-1 ReceptorInsulin GlargineSodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide-1 Receptor AgonistsAgedCardiovascular DiseasesDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMetforminMiddle AgedVeteransCohort StudiesTreatment Outcome

Keywords

MedicineHazard ratioType 2 diabetesInsulin glargineInternal medicineInsulinProportional hazards modelCohortDiabetes mellitusEndocrinologyMetforminBody mass indexCohort studyConfidence intervalCardiovascular diseaseInsulin TherapySglt2 InhibitorDatabase ResearchGlp‐1

Sustainable Development Goals

SDG 0: Good health and well-being